Is anesthesiology going soft? Trends in fragile pharmacology

Anesthesiology

Volumn 111, Issue 2, 2009, Pages 229-230

  Egan, Talmage D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CNS 7557; CORTICOSTEROID; ESMOLOL; ETOMIDATE; REMIFENTANIL; SUXAMETHONIUM; THRX 918661; THRX 9188661; UNCLASSIFIED DRUG;

ANESTHESIA; ANESTHETIC EQUIPMENT; CLINICAL PRACTICE; EDITORIAL; HEMODYNAMICS; PRIORITY JOURNAL;

EID: 68249162170     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181ae8460     Document Type: Editorial

References (14)

1. Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, Raines DE: Methoxycarbonyl-etomidate: A novel rapidly metabolized and ultra-short acting etomidate analogue that does not produce prolonged adrenocortical suppression. ANESTHESIOLOGY 2009; 111:240-9
2. Kilpatrick GJ, Tilbrook GS: Drug development in anaesthesia: Industrial perspective. Curr Opin Anaesthesiol 2006; 19:385-9
3. Bodor N, Buchwald P: Soft drug design: General principles and recent applications. Med Res Rev 2000; 20:58-101
4. Bodor N, Buchwald P: Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. Mol Biotechnol 2004; 26:123-32
5. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D: Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984; 310:1415-21
6. Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ: Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics. J Med Chem 1991; 34:2202-8
7. Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
8. Scott LJ, Perry CM: Remifentanil: A review of its use during the induction and maintenance of general anaesthesia. Drugs 2005; 65:1793-823
9. Lockridge O: Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 1990; 47:35-60
10. Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, Eddington ND: Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. J Pharm Sci 1997; 86:1278-82
11. Sneyd JR: Recent advances in intravenous anaesthesia. Br J Anaesth 2004; 93:725-36
12. Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, Wiard RP, Feldman PL, Collins H, Waszczak BL, Tilbrook GS: CNS 7056: A novel ultra-short-acting Benzodiazepine. ANESTHESIOLOGY 2007; 107:60-6
13. Stafford JA, Pacofsky GJ, Cox RF, Cowan JR, Dorsey GF Gonzales SS, Jung DK, Koszalka GW, McIntyre MS, Tidwell JH, Wiard RP, Feldman PL: Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists. Bioorg Med Chem Lett 2002; 12:3215-8
14. Jones RK, Caldwell JE, Brull SJ, Soto RG: Reversal of profound rocuronium-induced blockade with sugammadex: A randomized comparison with neostigmine. ANESTHESIOLOGY 2008; 109:816-24